Pay in 4 interest-free payments of $6.69 Learn more
Ships within 48 hours · Estimated delivery Aug 31 - Sep 5
The standard approach starts everyone at a low dose of 0.25 mg weekly, regardless of body weight
Some clients report feeling refreshed or noticing clarity or radiance shortly after treatment
Maintenance Treatments Some individuals may choose to have additional PCDC injections to enhance or maintain their results, especially if they experience weight fluctuations or desire a further reduction in fat
Oral metabolic franchise, a broader portfolio of oral small molecule candidates targeting metabolic disease beyond the lead GLP-1 program Recent Highlights: In May 2026, Structure reported positive end-of-Phase 2 feedback from the FDA for aleniglipron, clearing the way to begin a Phase 3 registrational program for chronic weight management in Q3 2026
US$ 24.84
US$ 23.59
US$ 23.34
US$ 28.17
